Cresco Labs Inc. (OTC: CRLBF)

Cresco Labs Inc is one of the largest vertically integrated multistate cannabis operators in the United States. The company is licensed to cultivate manufacture and sell retail and medical cannabis products through its national dispensary brand Sunnyside and by wholesaling to third party retail stores. Cresco Labs builds a portfolio of proprietary brands that include flower vapes edibles and concentrates aimed at diverse consumer occasions. The firm operates cultivation sites manufacturing facilities and a distribution network that supplies both its own stores and external retailers. As of early 2026 the company maintained a presence in multiple states including Illinois Pennsylvania Ohio New York Massachusetts Michigan and Florida.

Revenue is generated primarily from the sale of cannabis products to consumers and to other licensed retailers. Retail revenue comes from the Sunnyside dispensary chain where the company sells its own branded products as well as third party cannabis goods. Wholesale revenue is derived from the cultivation manufacture and distribution of cannabis flower extracts edibles and vape cartridges to independent dispensaries and other licensed operators. The company also earns income from licensing its brand portfolio and from providing ancillary services such as compliance support to partners. Overall sales are driven by product volume pricing power and the expansion of its retail footprint.

The company operates through the following segments: consolidated wholesale and consolidated retail.

• The consolidated wholesale segment encompasses the cultivation manufacturing and distribution activities that supply cannabis products to third party retailers.

• It includes the company's owned farms extraction labs and packaging facilities where flower concentrates vape cartridges and edibles are produced.

• This segment manages the supply chain from seed to sale ensuring product quality regulatory compliance and timely delivery to wholesale customers.

• It also oversees the portfolio of owned brands such as Cresco High Supply Good News Wonder Wellness FloraCal Remedi Mindy's and Loud r which are marketed to external dispensaries.

• The consolidated retail segment consists of the Sunnyside dispensary network where the company sells cannabis directly to consumers.

• It operates storefronts that offer a curated selection of flower vapes edibles and accessories alongside educational services and community engagement initiatives.

• The segment leverages an ecommerce platform to enable online ordering and pickup or delivery where permitted.

• Retail locations serve as a showcase for the company's brand portfolio and provide direct consumer feedback that informs product development and inventory management.

Within the United States cannabis industry Cresco Labs holds a leading position among multistate operators due to its scale brand diversity and integrated supply chain.

The firm competes with other large operators such as Curaleaf Green Thumb Industries Trulieve and Verano Holdings.

Competitive advantages include a nationally recognized retail banner a deep portfolio of proprietary product brands and a proven ability to place its goods on the shelves of high traffic dispensaries.

The company's focus on consistent product formulation and rigorous testing helps build consumer trust and supports repeat purchases.

The company serves a broad base of adult use and medical cannabis consumers patients and licensed retail partners.

Its retail customers are individuals seeking wellness recreation or symptom relief who visit Sunnyside stores or use its online channels.

Wholesale customers are independent dispensaries and other licensed operators that purchase cannabis flower extracts and infused products for resale.

While specific partner names are not disclosed in the filing the customer base spans multiple states and includes both large chain dispensaries and independent stores.